TGA and the Australian Register of Therapeutic Goods (ARTG)

The TGA (Therapeutic Goods Administration), part of the Australian Department of Health, regulates medical devices under the Therapeutic Goods Act 1989 and the Therapeutic Goods (Medical Devices) Regulations 2002. All medical devices must be included in the Australian Register of Therapeutic Goods (ARTG) before they can be supplied in Australia. The ARTG is a public register — checking whether a device is listed confirms its Australian regulatory status. Registration in the ARTG is the responsibility of the Australian Sponsor (the local regulatory representative) rather than the manufacturer directly.

Australian Sponsor: The Key Requirement

Unlike CE marking (where an EU Authorised Representative is the manufacturer's regulatory representative), in Australia the device is actually registered in the ARTG by an Australian Sponsor — a company or individual incorporated or resident in Australia who takes responsibility for the device in the Australian market. The Sponsor applies to the TGA, maintains the ARTG entry, and is responsible for incident reporting and recall activities. Turkish manufacturers must appoint an Australian Sponsor before any ARTG application can be submitted. The Sponsor is typically the Australian distributor or a specialist regulatory affairs company that acts as Sponsor for multiple foreign manufacturers.

TGA Classification System

Australia uses a similar risk-based classification to the EU: Class I (low risk, self-declared), Class IIa (low-medium risk), Class IIb (medium-high risk), Class III (high risk), and Active Implantable Medical Devices (AIMD). The classification rules align closely with the EU MDR Annex VIII rules, making Australian classification assessment straightforward for manufacturers who have already classified under EU MDR. Classification determines the conformity assessment pathway required.

TGA Conformity Assessment Pathways

For Class II and above devices, TGA allows three conformity assessment pathways: (1) TGA Conformity Assessment Certificate — a TGA-conducted audit of the manufacturer's QMS and technical documentation, similar to a Notified Body audit; (2) EC Certificate of Conformity (CE marking recognition) — TGA accepts a valid CE certificate under EU MDR from an EU Notified Body as the primary evidence for the ARTG application, significantly reducing assessment requirements; (3) Approved Overseas Regulatory Approval — TGA recognises approvals from certain trusted regulators (FDA 510(k), Health Canada, Japan PMDA) as primary evidence. For Turkish CE-marked manufacturers, the EC Certificate pathway is the most efficient — it typically requires only the CE certificate, Declaration of Conformity, and summary Technical Documentation rather than a full TGA audit.

ARTG Application Process Step by Step

Step 1: Classify the device under Australian classification rules (align with EU MDR classification). Step 2: Appoint an Australian Sponsor. Step 3: Prepare the ARTG application through the TGA Business Services (TBS) online portal. Step 4: Submit required documents — for the EC Certificate pathway: current CE certificate, Declaration of Conformity, device labelling and IFU, and the Sponsor's Australian Business Number (ABN). Step 5: Pay ARTG application fee (AUD 670–2,600 depending on device class and pathway). Step 6: TGA review — typically 60 business days for Class II devices via the EC Certificate pathway. Step 7: ARTG inclusion — device is listed in the ARTG and can be commercially supplied in Australia. Annual ARTG listing fees apply (AUD 290–4,600 depending on class).

Post-Registration Obligations

Once registered in the ARTG, the Australian Sponsor has ongoing obligations: annual ARTG renewal fees, post-market incident reporting (serious adverse events must be reported to TGA within 30 days; imminent hazards within 2 days), Field Safety Corrective Actions must be coordinated with TGA, and the Sponsor must maintain accurate records of device supply. The TGA conducts post-market surveillance audits and can inspect both the Sponsor and the manufacturer. Changes to the device that affect safety or performance may require TGA notification or re-assessment before implementation.

Australia as a Gateway to the Wider Region

For Turkish manufacturers, TGA registration has value beyond Australia itself. New Zealand has a mutual recognition arrangement with Australia — ARTG-registered devices can often be supplied in New Zealand without separate registration. Australia's alignment with international regulatory standards also makes TGA registration a respected quality credential in Pacific Island nations, Southeast Asia, and other markets that look to Australia's TGA as a reference regulatory standard. Combined with CE marking, TGA registration gives Turkish manufacturers access to the Asia-Pacific premium healthcare segment.

Conclusion

Australia is one of the most accessible premium export markets for Turkish medical device manufacturers who are already CE-marked. The TGA's explicit recognition of EU MDR certificates as the primary conformity assessment pathway means that registration — through a qualified Australian Sponsor — is relatively straightforward, fast, and cost-effective. For Turkish manufacturers building a global market portfolio, Australia should be on the priority list alongside EU expansion, as it provides high-value market access at a modest incremental investment over CE marking.